Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-23

Clinical Trial Update: Zoledronic Acid in Acute Spinal Cord Injury [Phase 3]

View source ↗

Summary

Phase 3 trial update for zoledronic acid in acute spinal cord injury has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Spinal Cord Injury | Phase 3 | Status: COMPLETED | Results posted: 2023-05-23